Re: Activity and Safety of ODM-201 in Patients with Progressive Metastatic Castration-resistant Prostate Cancer (ARADES): An Open-label Phase 1 Dose-escalation and Randomised Phase 2 Dose Expansion Trial
(2015) In European Urology 67(2). p.348-349
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/5085003
- author
- Bjartell, Anders LU
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- European Urology
- volume
- 67
- issue
- 2
- pages
- 348 - 349
- publisher
- Elsevier
- external identifiers
-
- wos:000347033500045
- scopus:84920642245
- pmid:25760250
- pmid:25760250
- ISSN
- 1873-7560
- DOI
- 10.1016/j.eururo.2014.11.019
- language
- English
- LU publication?
- yes
- id
- 6ee90f7b-f8e1-474d-b53d-6c0a36dd1b7d (old id 5085003)
- date added to LUP
- 2016-04-01 14:46:13
- date last changed
- 2022-01-28 02:25:50
@misc{6ee90f7b-f8e1-474d-b53d-6c0a36dd1b7d, author = {{Bjartell, Anders}}, issn = {{1873-7560}}, language = {{eng}}, number = {{2}}, pages = {{348--349}}, publisher = {{Elsevier}}, series = {{European Urology}}, title = {{Re: Activity and Safety of ODM-201 in Patients with Progressive Metastatic Castration-resistant Prostate Cancer (ARADES): An Open-label Phase 1 Dose-escalation and Randomised Phase 2 Dose Expansion Trial}}, url = {{http://dx.doi.org/10.1016/j.eururo.2014.11.019}}, doi = {{10.1016/j.eururo.2014.11.019}}, volume = {{67}}, year = {{2015}}, }